US Stock MarketDetailed Quotes

ONCT Oncternal Therapeutics

Watchlist
  • 8.1790
  • -0.4560-5.28%
Close May 10 16:00 ET
24.21MMarket Cap-663P/E (TTM)

Oncternal Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-7.19%41.71M
-19.13%9.64M
-8.26%10.39M
-19.08%9.55M
22.51%12.14M
43.30%44.95M
47.46%11.92M
17.52%11.33M
53.38%11.8M
66.34%9.91M
Selling and administrative expenses
-5.28%12.75M
-0.76%3.26M
-5.24%3.09M
-4.68%3.07M
-9.89%3.32M
16.06%13.46M
25.59%3.29M
16.52%3.27M
-4.61%3.23M
31.68%3.68M
-General and administrative expense
-5.28%12.75M
-0.76%3.26M
-5.24%3.09M
-4.68%3.07M
-9.89%3.32M
16.06%13.46M
25.59%3.29M
16.52%3.27M
-4.61%3.23M
31.68%3.68M
Research and development costs
-9.78%29.75M
-24.19%6.67M
-11.45%7.48M
-24.93%6.58M
29.40%9.03M
36.93%32.98M
46.19%8.8M
-5.81%8.44M
68.74%8.76M
78.35%6.98M
Other operating expenses
47.32%-785K
-73.68%-297K
53.14%-179K
44.50%-106K
72.79%-203K
65.47%-1.49M
69.24%-171K
82.05%-382K
78.37%-191K
0.27%-746K
Operating profit
7.19%-41.71M
19.13%-9.64M
8.26%-10.39M
19.08%-9.55M
-22.51%-12.14M
-43.30%-44.95M
-47.46%-11.92M
-17.52%-11.33M
-53.38%-11.8M
-66.34%-9.91M
Net non-operating interest income expense
187.64%2.24M
-8.35%472K
164.00%528K
972.22%579K
8,100.00%656K
2,254.55%777K
7,257.14%515K
2,757.14%200K
575.00%54K
-27.27%8K
Non-operating interest income
187.64%2.24M
-8.35%472K
164.00%528K
972.22%579K
8,100.00%656K
2,254.55%777K
7,257.14%515K
2,757.14%200K
575.00%54K
-27.27%8K
Other net income (expense)
Income before tax
10.62%-39.48M
19.61%-9.16M
11.35%-9.86M
23.64%-8.97M
-15.98%-11.49M
-40.97%-44.17M
-41.21%-11.4M
-15.52%-11.13M
-52.84%-11.74M
-66.51%-9.9M
Income tax
Net income
10.62%-39.48M
19.61%-9.16M
11.35%-9.86M
23.64%-8.97M
-15.98%-11.49M
-40.97%-44.17M
-41.21%-11.4M
-15.52%-11.13M
-52.84%-11.74M
-66.51%-9.9M
Net income continuous Operations
10.62%-39.48M
19.61%-9.16M
11.35%-9.86M
23.64%-8.97M
-15.98%-11.49M
-40.97%-44.17M
-41.21%-11.4M
-15.52%-11.13M
-52.84%-11.74M
-66.51%-9.9M
Minority interest income
Net income attributable to the parent company
10.62%-39.48M
19.61%-9.16M
11.35%-9.86M
23.64%-8.97M
-15.98%-11.49M
-40.97%-44.17M
-41.21%-11.4M
-15.52%-11.13M
-52.84%-11.74M
-66.51%-9.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
10.62%-39.48M
19.61%-9.16M
11.35%-9.86M
23.64%-8.97M
-15.98%-11.49M
-40.97%-44.17M
-41.21%-11.4M
-15.52%-11.13M
-52.84%-11.74M
-66.51%-9.9M
Basic earnings per share
20.06%-13.43
24.25%-3.03
19.05%-3.4
34.78%-3
0.00%-4
-31.25%-16.8
-25.00%-4
-10.53%-4.2
-43.75%-4.6
-66.67%-4
Diluted earnings per share
20.06%-13.43
24.25%-3.03
19.05%-3.4
34.78%-3
0.00%-4
-31.25%-16.8
-25.00%-4
-10.53%-4.2
-43.75%-4.6
-66.67%-4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -7.19%41.71M-19.13%9.64M-8.26%10.39M-19.08%9.55M22.51%12.14M43.30%44.95M47.46%11.92M17.52%11.33M53.38%11.8M66.34%9.91M
Selling and administrative expenses -5.28%12.75M-0.76%3.26M-5.24%3.09M-4.68%3.07M-9.89%3.32M16.06%13.46M25.59%3.29M16.52%3.27M-4.61%3.23M31.68%3.68M
-General and administrative expense -5.28%12.75M-0.76%3.26M-5.24%3.09M-4.68%3.07M-9.89%3.32M16.06%13.46M25.59%3.29M16.52%3.27M-4.61%3.23M31.68%3.68M
Research and development costs -9.78%29.75M-24.19%6.67M-11.45%7.48M-24.93%6.58M29.40%9.03M36.93%32.98M46.19%8.8M-5.81%8.44M68.74%8.76M78.35%6.98M
Other operating expenses 47.32%-785K-73.68%-297K53.14%-179K44.50%-106K72.79%-203K65.47%-1.49M69.24%-171K82.05%-382K78.37%-191K0.27%-746K
Operating profit 7.19%-41.71M19.13%-9.64M8.26%-10.39M19.08%-9.55M-22.51%-12.14M-43.30%-44.95M-47.46%-11.92M-17.52%-11.33M-53.38%-11.8M-66.34%-9.91M
Net non-operating interest income expense 187.64%2.24M-8.35%472K164.00%528K972.22%579K8,100.00%656K2,254.55%777K7,257.14%515K2,757.14%200K575.00%54K-27.27%8K
Non-operating interest income 187.64%2.24M-8.35%472K164.00%528K972.22%579K8,100.00%656K2,254.55%777K7,257.14%515K2,757.14%200K575.00%54K-27.27%8K
Other net income (expense)
Income before tax 10.62%-39.48M19.61%-9.16M11.35%-9.86M23.64%-8.97M-15.98%-11.49M-40.97%-44.17M-41.21%-11.4M-15.52%-11.13M-52.84%-11.74M-66.51%-9.9M
Income tax
Net income 10.62%-39.48M19.61%-9.16M11.35%-9.86M23.64%-8.97M-15.98%-11.49M-40.97%-44.17M-41.21%-11.4M-15.52%-11.13M-52.84%-11.74M-66.51%-9.9M
Net income continuous Operations 10.62%-39.48M19.61%-9.16M11.35%-9.86M23.64%-8.97M-15.98%-11.49M-40.97%-44.17M-41.21%-11.4M-15.52%-11.13M-52.84%-11.74M-66.51%-9.9M
Minority interest income
Net income attributable to the parent company 10.62%-39.48M19.61%-9.16M11.35%-9.86M23.64%-8.97M-15.98%-11.49M-40.97%-44.17M-41.21%-11.4M-15.52%-11.13M-52.84%-11.74M-66.51%-9.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 10.62%-39.48M19.61%-9.16M11.35%-9.86M23.64%-8.97M-15.98%-11.49M-40.97%-44.17M-41.21%-11.4M-15.52%-11.13M-52.84%-11.74M-66.51%-9.9M
Basic earnings per share 20.06%-13.4324.25%-3.0319.05%-3.434.78%-30.00%-4-31.25%-16.8-25.00%-4-10.53%-4.2-43.75%-4.6-66.67%-4
Diluted earnings per share 20.06%-13.4324.25%-3.0319.05%-3.434.78%-30.00%-4-31.25%-16.8-25.00%-4-10.53%-4.2-43.75%-4.6-66.67%-4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg